14.26
0.07 (0.46%)
| Penutupan Terdahulu | 14.19 |
| Buka | 14.29 |
| Jumlah Dagangan | 294,906 |
| Purata Dagangan (3B) | 1,326,893 |
| Modal Pasaran | 657,538,944 |
| Harga / Pendapatan (P/E TTM) | 10.64 |
| Harga / Pendapatan (P/E Ke hadapan) | 5.36 |
| Harga / Jualan (P/S) | 1.37 |
| Harga / Buku (P/B) | 1.13 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 31 Oct 2024 - 4 Nov 2024 |
| Margin Keuntungan | -13.06% |
| Margin Operasi (TTM) | 13.02% |
| EPS Cair (TTM) | -1.98 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 2.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -26.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 85.97% |
| Nisbah Semasa (MRQ) | 2.25 |
| Aliran Tunai Operasi (OCF TTM) | 203.84 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 169.56 M |
| Pulangan Atas Aset (ROA TTM) | 4.17% |
| Pulangan Atas Ekuiti (ROE TTM) | -11.48% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Pacira BioSciences, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 0.5 |
| Purata | -0.13 |
|
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 2.15% |
| % Dimiliki oleh Institusi | 114.51% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 39.00 (HC Wainwright & Co., 173.59%) | Beli |
| Median | 19.50 (36.79%) | |
| Rendah | 16.00 (RBC Capital, 12.24%) | Pegang |
| Purata | 23.50 (64.85%) | |
| Jumlah | 2 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 17.71 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 04 Dec 2024 | 39.00 (173.59%) | Beli | 19.09 |
| Barclays | 12 Nov 2024 | 17.00 (19.26%) | Pegang | 16.80 |
| Needham | 08 Nov 2024 | 22.00 (54.33%) | Beli | 17.24 |
| RBC Capital | 07 Nov 2024 | 16.00 (12.24%) | Pegang | 17.70 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |